Financial Incentives to Promote Stimulant Abstinence in a Community-Based Syringe Exchange Program

Sponsor
University of Vermont (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05787847
Collaborator
(none)
40
2
12

Study Details

Study Description

Brief Summary

The goal of this randomized control pilot study is to learn about a financial incentives intervention among individuals who use stimulants and take part in a community-based syringe exchange program. The main question it aims to answer is how financial incentives for not using stimulants will impact stimulant use. Participants in the experimental group will have the opportunity to earn financial incentives for providing a negative urine sample for stimulants using a point-of-care test, which indicates abstinence from stimulant use, along with health education on the health risks of stimulant use and substance injection. Researchers will compare the experimental group to the control group who will receive health education on the health risks of stimulants use and injection.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Health Education plus Incentives for Abstinence
  • Behavioral: Health Education
N/A

Detailed Description

We are proposing a two condition, parallel groups, randomized control pilot study to evaluate the efficacy of a financial incentives intervention among individuals who use stimulants and take part in a community-based syringe exchange program. The study design will include recruiting service recipients who already participate in programs offered by a syringe exchange program.The experimental group will have the opportunity to earn financial incentives contingent on providing a negative urine sample for stimulants using a point-of-care test, which indicates abstinence from stimulant use, in addition to health education on the health risks of stimulant use and substance injection. The control group will receive health education on the health risks of stimulants use and injection. All participants will participate in their syringe exchange services as usual. We chose the health education as the control because participants across both conditions already receive the services provided by the syringe exchange program. Moreover, this control condition will help control for a potential type of between-groups variability.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Financial Incentives to Promote Stimulant Abstinence in a Community-Based Syringe Exchange Program
Anticipated Study Start Date :
May 1, 2023
Anticipated Primary Completion Date :
May 1, 2024
Anticipated Study Completion Date :
May 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Other: Health Education

Behavioral: Health Education
The Health Education condition is based on a previous intervention used as a control in a number of other studies. Sessions consist of an educational program addressing a variety of health, wellness, and lifestyle topics adapted from a previously implemented wellness manual.

Experimental: Health Education plus Incentives for Abstinence

Behavioral: Health Education plus Incentives for Abstinence
Participants in the experimental condition will have the opportunity to earn financial incentives for abstaining from stimulant use, in addition to receiving the same health education as the control condition.

Outcome Measures

Primary Outcome Measures

  1. stimulant free urine sample [12 weeks]

    all samples will be assessed using point-of-care test conducted at the center.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • (a) be 18 years or older, (b) report using stimulants in the past 30 days, (c) meet the DSM-5 diagnosis for stimulant use disorder at a moderate or severe level (i.e., 6 or more of the 11 DSM criteria), and (d) participation in services at syringe exchange program
Exclusion Criteria:
  • (a) failure to meet one or more inclusionary criteria above, (b) individuals who are cognitively impaired by their drug use or psychiatric conditions that could preclude informed consent.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • University of Vermont

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
richard rawson, Research Professor, University of Vermont
ClinicalTrials.gov Identifier:
NCT05787847
Other Study ID Numbers:
  • UVermont - FI for StimUD
First Posted:
Mar 28, 2023
Last Update Posted:
Mar 28, 2023
Last Verified:
Mar 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Mar 28, 2023